Linagliptin ameliorates acetic acid-induced colitis via modulating AMPK/SIRT1/PGC-1 and JAK2/STAT3 signaling pathway in rats
Tam CS, Rigas G, Heilbronn LK, Matisan T, Probst Y, Talbot M
Alternative repletion strategies have focused on oral administration of GSH precursors (e.g., cysteine and glycine supplementation 9 ), and intravenous administration of GSH, 10 which although promising, is invasive and inconvenient, and therefore unlikely to be a practical solution
Halal Research Center of IRI, FDA, Tehran, Iran
Other current hypoglycemic drugs lack evidence of their effect on liver fibrosis and are not considered drugs for T2D patients with MASLD
Although a recent clinical trial failed to show significant benefit, Scott Kanoski, PhD, professor of biological sciences at University of Southern California, cautions against closing the door on this area